Ligne de temps

Bruno Charbit
Ingénieur(e) de Recherche
25 nov. 2022
publication

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Lire plus
15 nov. 2022
publication

Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.

Lire plus
28 juin 2022
publication

Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.

Lire plus
20 juin 2022
publication

Variability of Primary Sjögren’s Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA-DQ Locus.

Lire plus
28 mars 2022
news

New publication – Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency

Lire plus
09 mars 2022
publication

Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes.

Lire plus
14 févr. 2022
publication

Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC transplanted SCID patients with IL2RG/JAK3 deficiency.

Lire plus
01 janv. 2022
publication

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.

Lire plus
01 déc. 2021
publication

Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak.

Lire plus
17 nov. 2021
publication

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.

Lire plus
01 sept. 2021
publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Lire plus
18 août 2021
news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Lire plus
01 août 2021
publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Lire plus
17 juil. 2021
publication

Platelet activation in critically ill COVID-19 patients.

Lire plus
04 juin 2021
publication

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients.

Lire plus
04 janv. 2021
publication

Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers.

Lire plus
10 déc. 2020
publication

Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults.

Lire plus
16 oct. 2020
publication

Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.

Lire plus
13 juil. 2020
publication

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

Lire plus
01 juin 2020
publication

Antibody-coated microbiota in nasopharynx of healthy individuals and IVIg-treated patients with hypogammaglobulinemia.

Lire plus
27 mai 2020
publication

Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.

Lire plus
10 avr. 2020
team

Group : Milieu Intérieur

Lire plus
23 sept. 2019
event

Agilent Cell Analysis Seminar and Seahorse Workshop

Lire plus
10 juil. 2019
publication

Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment

Lire plus
05 sept. 2018
publication

Human thymopoiesis is influenced by a common genetic variant within the TCRA-TCRD locus.

Lire plus
27 juil. 2018
publication

Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.

Lire plus
16 janv. 2018
publication

Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges.

Lire plus
02 sept. 2015
team

Biomarqueurs

Lire plus
02 juil. 2015
project

Antiviral Immunity, Biotherapy And Vaccines

Lire plus